logo

Altimmune Inc. (ALT)



Trade ALT now with
  Date
  Headline
6/16/2021 7:13:09 AM Altimmune Announces Positive Interim Data From ALT-801 Phase 1 Trial In Healthy Overweight And Obese Volunteers
12/30/2020 8:13:23 AM Altimmune Enrolls First Patient In Its Multinational Phase 2 Clinical Trial Of HepTcell
12/24/2020 10:04:41 AM Stock Alert: Altimmune Loses 6%
11/25/2020 7:13:53 AM Altimmune Submits IND Application For AdCOVID A Single-dose Intranasal COVID-19 Vaccine
11/16/2020 10:02:37 AM Stock Alert: Altimmune Down 9%
10/13/2020 10:14:16 AM Stock Alert: Altimmune Jumps 19%
9/14/2020 10:57:37 AM Stock Alert: Altimmune Up 10%
9/1/2020 7:17:01 AM Altimmune Announces Completion Of Multiple Dose Toxicity, Toxicokinetic Studies Of ALT-801
8/26/2020 7:02:46 AM Altimmune Announces Preclinical Data Presentation On ALT-801
8/7/2020 7:15:19 AM Altimmune Completes Enrollment In Its Phase 1b Clinical Trial Of NasoShield